Hypertension and lower walking speed in the elderly: the Three-City study.
OBJECTIVE
The brain is one of the main targets of hypertension. However, little is known about the relation between hypertension and motor performances. We studied the association between hypertension and walking speed in a cohort of elderly people.


METHODS
Analyses are based on participants (65-85 years) from the Dijon (France) center of the Three-City study (n = 3604), followed every 2 years. Persistent hypertension was defined by the use of antihypertensive drugs at baseline or at first follow-up, or by high blood pressure (> or =140/90 mmHg) at baseline and first follow-up. Walking speed was measured over 6 m, at baseline and fourth follow-up (n = 1774) after a mean (SD) duration of 7.0 (0.5) years. Brain MRI was performed in 1590 participants. Generalized linear models were used to assess the relation between hypertension and baseline walking speed or walking speed change.


RESULTS
At baseline, mean (SD) walking speed (m/s) was lower in hypertensive patients [1.51 (0.31)] than in nonhypertensive individuals [1.59 (0.30), P < 0.001]. During follow-up, hypertensive patients had a higher mean annual decline in walking speed [cm/s per year; 2.30 (3.4)] than nonhypertensive individuals [1.87 (3.3), P = 0.004]. The number of antihypertensive drugs was associated with lower walking speed at baseline and higher walking speed decline. Adjustment for MRI white matter abnormalities attenuated these relations.


CONCLUSIONS
Persistent hypertension was associated with both lower walking speed and higher decline in walking speed in the elderly. These results may be partly explained by white matter abnormalities and support the hypothesis of a contribution of vascular risk factors to motor dysfunction.
Dumurgier
Julien
J
INSERM, U708, Hôpital de la Salpêtrière, Paris, France. julien.dumurgier@upmc.fr
Elbaz
Alexis
A
Dufouil
Carole
C
Tavernier
Béatrice
B
Tzourio
Christophe
C
D000368:Aged; D001921:Brain; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D012307:Risk Factors; D016138:Walking / Q000502:physiology*
Stroke. 2008 Apr;39(4):1233-9
18292379
Hypertension. 2004 Nov;44(5):625-30
15466662
Neurology. 1999 Dec 10;53(9):1948-52
10599763
Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):793-9
9923586
J Clin Epidemiol. 1996 Oct;49(10):1089-96
8826987
Hypertension. 2003 Dec;42(6):1206-52
14656957
Can J Sport Sci. 1989 Sep;14(3):178-81
2573412
N Engl J Med. 2003 Mar 27;348(13):1215-22
12660385
Neurology. 2000 Mar 28;54(6):1277-83
10746598
Neurology. 2008 Mar 18;70(12):935-42
18347315
J Am Geriatr Soc. 2008 Oct;56(10):1845-52
18811611
J Hypertens. 2003 Mar;21(3):509-17
12640244
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
10811152
J Am Geriatr Soc. 2008 Apr;56(4):621-9
18205758
Clin Sci (Lond). 2008 Feb;114(4):313-20
17916064
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
Neurology. 2006 Sep 26;67(6):985-90
17000965
Am J Epidemiol. 2007 Sep 1;166(5):599-605
17566063
Lancet. 2005 Jan 15-21;365(9455):217-23
15652604
Aging Clin Exp Res. 2005 Jun;17(3):211-6
16110734
Neuroradiology. 2008 Jan;50(1):31-42
17938898
J Card Fail. 2003 Jun;9(3):203-9
12815570
J Gerontol A Biol Sci Med Sci. 2000 Nov;55(11):M691-7
11078100
Ann Neurol. 2009 Jun;65(6):706-15
19557865
J Gerontol A Biol Sci Med Sci. 2006 Aug;61(8):839-43
16912102
J Am Geriatr Soc. 2009 Mar;57(3):432-40
19187412
Arch Phys Med Rehabil. 2008 May;89(5):865-72
18452733
JAMA. 2006 May 3;295(17):2018-26
16670410
Phys Ther. 2008 Nov;88(11):1365-74
18801861
Cleve Clin J Med. 2005 Jul;72(7):586, 589-90, 592-4 passim
16044655
Am J Hypertens. 2008 Jan;21(1):85-91
18091749
Am J Cardiol. 2003 Mar 1;91(5):643-5
12615286
Neuroepidemiology. 2003 Nov-Dec;22(6):316-25
14598854
Neuroepidemiology. 2006;26(1):52-60
16254454
Am J Epidemiol. 2008 Aug 15;168(4):355-7
18591202